Gag Mutations Strongly Contribute to HIV-1 Resistance to Protease Inhibitors in Highly Drug-Experienced Patients besides Compensating for Fitness Loss

Human immunodeficiency virus type 1 (HIV-1) resistance to protease inhibitors (PI) results from mutations in the viral protease (PR) that reduce PI binding but also decrease viral replicative capacity (RC). Additional mutations compensating for the RC loss subsequently accumulate within PR and in Ga...

Descripción completa

Detalles Bibliográficos
Autores principales: Dam, Elisabeth, Quercia, Romina, Glass, Bärbel, Descamps, Diane, Launay, Odile, Duval, Xavier, Kräusslich, Hans-Georg, Hance, Allan J., Clavel, François
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2652074/
https://www.ncbi.nlm.nih.gov/pubmed/19300491
http://dx.doi.org/10.1371/journal.ppat.1000345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2652074/
https://www.ncbi.nlm.nih.gov/pubmed/19300491
http://dx.doi.org/10.1371/journal.ppat.1000345

Ejemplares similares